ZC

@InstitutionalZC

Small cap and pre-IPO companies of interest to investors should try not to be so invisible. Here to help with tech not jabberwocky.

Vrijeme pridruživanja: kolovoz 2016.

Tweetovi

Blokirali ste korisnika/cu @InstitutionalZC

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @InstitutionalZC

  1. prije 34 minute

    Elixinol Global Abandons Australian Businesses to Focus on CBD and...

    Poništi
  2. prije 1 sat

    Kemin Names Leo Xie-Lei President of Kemin AquaScience™

    Poništi
  3. prije 2 sata

    3 Reasons Apple Stock Is Hitting New Highs

    Poništi
  4. prije 13 sati

    Ponder If You Will, Your Legacy

    Poništi
  5. prije 13 sati

    BioSpace Movers and Shakers, Jan. 31

    Poništi
  6. prije 14 sati

    GeNeuro raises €17.5M for multiple sclerosis clinical trial

    Poništi
  7. prije 15 sati

    Improving CAR-T therapy for cancer by regulating 2 proteins

    Poništi
  8. prije 15 sati

    Mammoth Biosciences nabs $45M for CRISPR drugs, diagnostics work

    Poništi
  9. prije 16 sati

    University of Pennsylvania researchers nab grant for CAR-T prostate cancer test

    Poništi
  10. prije 17 sati

    Sandoz Completes Acquisition of Aspen's Japanese Operations

    Poništi
  11. prije 17 sati

    China Coronavirus Update: An Interview with Infectious Disease Specialist Sean Beckmann

    Poništi
  12. 4. velj

    4 Lessons From Carlos Ghosn's Great Escape

    Poništi
  13. 4. velj

    Oil Prices Are Headed Much Lower

    Poništi
  14. 4. velj

    Canadian Cannabis Producers See Stocks Slide for 10th Consecutive...

    Poništi
  15. 4. velj

    How can companies reduce internal and external business risk?

    Poništi
  16. 4. velj

    The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus

    Poništi
  17. 4. velj

    American Cannabis Operator Index Drops 9% in January

    Poništi
  18. 3. velj

    Nanovalent: Animal data suggest superior efficacy and improved tolerability to approved chemotherapy

    Poništi
  19. 3. velj

    The Survival and Incidence Rate of Ewing Sarcoma; a National Population-based Study in Iran (2008-2015)

    Poništi
  20. 3. velj
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·